HIV prevention support for pregnant women in Zimbabwe
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study in Zimbabwe tests a program to help pregnant women start and stay on PrEP (medication that prevents HIV). It aims to make PrEP easier to use during pregnancy for women who are at risk of HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant.
- You are HIV-negative and at risk of getting HIV (for example, your partner's HIV status is unknown, you suspect they may have other partners, or you have had unprotected sex or a recent STI).
- You are 15 years old or older.
- You are willing to start HIV prevention medication (PrEP) before the study starts.
- You can safely bring your male partner to some study visits if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tries to reduce the psychological barriers that make it hard for pregnant or postpartum women to keep taking PrEP. It may help by offering support tailored to stress, trauma symptoms, or depression—especially soon after PrEP is started.
This study follows pregnant women and their babies to see how well HIV prevention medicines work during pregnancy. It aims to help keep both mother and baby healthy.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
This research studies how two types of long-acting birth control (a shot called cabotegravir and an implant) work in your body after pregnancy, and how they interact with HIV prevention or treatment. The study helps doctors understand the best doses and timing for women like you.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This trial tests whether STI testing during pregnancy helps more women start and stay on PrEP (a daily pill that prevents HIV). If you join, you'll help find better ways to protect both mother and baby from HIV.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.